Development of an IgG4-RD Responder Index

por Carruthers, Mollie N., Stone, John H., Deshpande, Vikram, Khosroshahi, Arezou
Publicado 2012

Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population

por Arleo, Timothy, Tong, David, Shabto, Julie, O’Keefe, Ghazala, Khosroshahi, Arezou
Publicado 2021

IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor

por Khosroshahi, Arezou, Ayalon, Rivka, Beck, Laurence H., Salant, David J., Bloch, Donald B., Stone, John H.
Publicado 2012

Outcomes of COVID-19 in a cohort of pediatric patients with rheumatic diseases

por Villacis-Nunez, D. Sofia, Rostad, Christina A., Rouster-Stevens, Kelly, Khosroshahi, Arezou, Chandrakasan, Shanmuganathan, Prahalad, Sampath
Publicado 2021

Rethinking Ormond’s Disease: “Idiopathic” Retroperitoneal Fibrosis in the Era of IgG4-Related Disease

por Khosroshahi, Arezou, Carruthers, Mollie N., Stone, John H., Shinagare, Shweta, Sainani, Nisha, Hasserjian, Robert P., Deshpande, Vikram
Publicado 2013

IgG4-Related Disease and Hypertrophic Pachymeningitis

por Wallace, Zachary S., Carruthers, Mollie N., Khosroshahi, Arezou, Carruthers, Robert, Shinagare, Shweta, Stemmer-Rachamimov, Anat, Deshpande, Vikram, Stone, John H.
Publicado 2013

A critical role for the programmed death ligand 1 in fetomaternal tolerance

por Guleria, Indira, Khosroshahi, Arezou, Ansari, Mohammed Javeed, Habicht, Antje, Azuma, Miyuki, Yagita, Hideo, Noelle, Randolph J., Coyle, Anthony, Mellor, Andrew L., Khoury, Samia J., Sayegh, Mohamed H.
Publicado 2005

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial

por Perugino, Cory, Culver, Emma L., Khosroshahi, Arezou, Zhang, Wen, Della-Torre, Emanuel, Okazaki, Kazuichi, Tanaka, Yoshiya, Löhr, Matthias, Schleinitz, Nicolas, Falloon, Judith, She, Dewei, Cimbora, Daniel, Stone, John H.
Publicado 2023

Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE

por Wallace, Daniel J, Alexander, Roberta Vezza, O'Malley, Tyler, Khosroshahi, Arezou, Hojjati, Mehrnaz, Loupasakis, Konstantinos, Alper, Jeffrey, Sherrer, Yvonne, Fondal, Maria, Kataria, Rajesh, Powell, Tami, Ibarra, Claudia, Narain, Sonali, Massarotti, Elena, Weinstein, Arthur, Dervieux, Thierry
Publicado 2019

Epigenetic programming underpins B cell dysfunction in human SLE

por Scharer, Christopher D., Blalock, Emily L., Mi, Tian, Barwick, Benjamin G., Jenks, Scott A., Deguchi, Tsuneo, Cashman, Kevin S., Neary, Bridget E., Patterson, Dillon G., Hicks, Sakeenah L., Khosroshahi, Arezou, Lee, F. Eun-Hyung, Wei, Chungwen, Sanz, Iñaki, Boss, Jeremy M.
Publicado 2019

Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatment

por Faliti, Caterina E., Anam, Fabliha A., Cheedarla, Narayanaiah, Woodruff, Matthew C., Usman, Sabeena Y., Runnstrom, Martin C., Van, Trinh T.P., Kyu, Shuya, Ahmed, Hasan, Morrison-Porter, Andrea, Quehl, Hannah, Haddad, Natalie S., Chen, Weirong, Cheedarla, Suneethamma, Neish, Andrew S., Roback, John D., Antia, Rustom, Khosroshahi, Arezou, Lee, F. Eun-Hyung, Sanz, Ignacio
Publicado 2023

SLE Antibody-Secreting Cells Are Characterized by Enhanced Peripheral Maturation and Survival Programs

por Chen, Weirong, Hong, So-Hee, Jenks, Scott A., Anam, Fabliha A., Tipton, Christopher M., Woodruff, Matthew C., Hom, Jennifer R., Cashman, Kevin S., Faliti, Caterina Elisa, Wang, Xiaoqian, Kyu, Shuya, Wei, Chungwen, Scharer, Christopher D., Mi, Tian, Hicks, Sakeenah, Hartson, Louise, Nguyen, Doan C., Khosroshahi, Arezou, Lee, Saeyun, Wang, Youliang, Bugrovsky, Regina, Ishii, Yusho, Lee, F. Eun-Hyung, Sanz, Ignacio
Publicado 2023

Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID

por Woodruff, Matthew C., Bonham, Kevin S., Anam, Fabliha A., Walker, Tiffany A., Faliti, Caterina E., Ishii, Yusho, Kaminski, Candice Y., Ruunstrom, Martin C., Cooper, Kelly Rose, Truong, Alexander D., Dixit, Adviteeya N., Han, Jenny E., Ramonell, Richard P., Haddad, Natalie S., Rudolph, Mark E., Yalavarthi, Srilakshmi, Betin, Viktoria, Natoli, Ted, Navaz, Sherwin, Jenks, Scott A., Zuo, Yu, Knight, Jason S., Khosroshahi, Arezou, Lee, F. Eun-Hyung, Sanz, Ignacio
Publicado 2023

Dysregulated naive B cells and de novo autoreactivity in severe COVID-19

por Woodruff, Matthew C., Ramonell, Richard P., Haddad, Natalie S., Anam, Fabliha A., Rudolph, Mark E., Walker, Tiffany A., Truong, Alexander D., Dixit, Adviteeya N., Han, Jenny E., Cabrera-Mora, Monica, Runnstrom, Martin C., Bugrovsky, Regina, Hom, Jennifer, Connolly, Erin C., Albizua, Igor, Javia, Vidhi, Cashman, Kevin S., Nguyen, Doan C., Kyu, Shuya, Singh Saini, Ankur, Piazza, Michael, Tipton, Christopher M., Khosroshahi, Arezou, Gibson, Greg, Martin, Greg S., Maier, Cheryl L., Esper, Annette, Jenks, Scott A., Lee, F. Eun-Hyung, Sanz, Ignacio
Publicado 2022